These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33421446)

  • 1. Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials.
    Weiser R; Rye PD; Mahenthiralingam E
    J Microbiol Methods; 2021 Feb; 181():106133. PubMed ID: 33421446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.
    da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA
    BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
    Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
    Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F; Jonasson J
    Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.
    De Boeck K; Malfroot A; Van Schil L; Lebecque P; Knoop C; Govan JR; Doherty C; Laevens S; Vandamme P;
    Eur Respir J; 2004 Jun; 23(6):851-6. PubMed ID: 15218997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
    McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
    J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples.
    Brown AR; Govan JR
    J Clin Microbiol; 2007 Jun; 45(6):1920-6. PubMed ID: 17460050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
    Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
    Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of co-colonizing cystic fibrosis-associated pathogens by Pseudomonas aeruginosa and Burkholderia multivorans.
    Costello A; Reen FJ; O'Gara F; Callaghan M; McClean S
    Microbiology (Reading); 2014 Jul; 160(Pt 7):1474-1487. PubMed ID: 24790091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
    Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
    Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal diversity among Burkholderia cepacia complex isolates from cystic fibrosis patients in a reference unit.
    Barrado L; Martinez MT; Villa J; Orellana MÁ; Viedma E; Chaves F
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):665-8. PubMed ID: 23850187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients.
    Al-Momani H; Perry A; Stewart CJ; Jones R; Krishnan A; Robertson AG; Bourke S; Doe S; Cummings SP; Anderson A; Forrest T; Griffin SM; Brodlie M; Pearson J; Ward C
    Sci Rep; 2016 Jun; 6():26985. PubMed ID: 27245316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of postage on recovery of pathogens from cystic fibrosis sputum samples.
    Hatfield L; Bianco B; Gavillet H; Burns P; Rivett D; Smith M; Jones A; van der Gast C; Horsley A
    J Cyst Fibros; 2023 Sep; 22(5):816-822. PubMed ID: 36934050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
    Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
    Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
    [No Abstract]   [Full Text] [Related]  

  • 19. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
    Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
    Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
    Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
    J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.